From September 18 to 20, the 10th China (Taizhou) International Medical Expo 
was held in China Medical City (CMS), according to China (Taizhou) Medical Expo 
News Center. 

This is a display platform for sharing and exchanges between pharmaceutical 
companies. It is also a learning platform for the public to understand the 
pharmaceutical industry and for cooperation in information, technology and 
talent. This year's expo brought together two Nobel Prize laurates, 11 domestic 
and foreign academicians, and 102 experts. More than 4,000 guests gathered 
together. 33 conference forums focused on cutting-edge technology, interpreting 
the latest situation and the promotion of product achievements in biomedical 
field. It has outstanding authority and extensive influence in the biomedical 
industry at home and abroad.

The three-day exhibition attracted 886 exhibitors from 23 countries and regions 
including China, the United States, Britain, France, Japan and South Korea. 
Taizhou Yangtze River Pharmaceutical Group, Jumpcan Pharmaceutical, Eli Lilly 
and Company, AstraZeneca, Nestle and other world's leading pharmaceutical 
companies participated in the exhibition, bringing advanced medical technology, 
core technologies and high-end products in the field of biomedicine. During the 
exhibition, CMS signed a contract with 30 major projects with a total 
investment of 6.15 billion yuan.

With the advantage of industrial clusters, CMS has attracted more than 1,000 
enterprises to settle in and has gathered more than 70 well-known universities 
and pharmaceutical R&D institutions at home and abroad to successfully declare 
more than 2,000 "world-class" medical innovation. CMS actively integrates 
high-quality industry resources, optimizes the investment environment. It 
successfully builds six characteristic bases of vaccines, antibodies, chemical 
medicament, high-performance medical equipment, Chinese medicine, and special 
medical foods. It has become a famous medical city for gathering technology, 
talents, information and projects.

In 2019, CMS has launched a new journey of "Second Entrepreneurship" and will 
continue to strive to build the largest bio-pharmaceutical industry base in 
China with the most complete industrial chain and develop powerful "Voice of 
Taizhou" to the global pharmaceutical industry, and tell the "Taizhou Story" of 
the Chinese pharmaceutical industry to the world.

Source: China (Taizhou) Medical Expo News Center

Image Attachments Links:

   Link: https://iop.asianetnews.net/view-attachment?attach-id=346533

   Caption: The scene of 2019 China (Taizhou) International Medical Expo